Retinal Solutions LLC
USPTO PatentsView assignee record - 8 granted patents across 4 technology areas, recorded in grant years 2016–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Retinal ranks #33,062 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 4 technology areas.
- #33,062
- of 49,997 US assignees by volume
- 8th percentile
- by Innovation Score (20.9/100)
- 10.4
- avg claims per patent
- +67%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R33062 · US Corporation #33,062 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 8 grants
- MID-PACK #33,062/49,997
- PHOTO-FINISH Remo
- CPC-NARROW A61K · 4 areas
- INNOV-THIN 20.9/100
- CLAIMS-PAR 10.4 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +67% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Remo, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Retinal’s 20.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Retinal
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Retinal Solutions · this assignee 21
Retinal Solutions · this assignee
21 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Retinal's Innovation Score is 20.9/100 (8th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Retinal?
Each dot is one of Retinal’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Retinal’s own 10.4 claims/patent is at or below the 14.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Retinal's grants concentrate
Retinal Solutions LLC is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2016. By volume, Retinal sits between Remo, Inc. and Rheinmetall AIR Defence AG.
Who files at Retinal's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Remo
Remo, Inc.
8 patents
- Renescience A/S
Renescience A/S
8 patents
- Resilux
Resilux N.V.
8 patents
- Respire Medical H…
Respire Medical Holdings LLC
8 patents
- REV Robotics
REV Robotics LLC
8 patents
- RF Venue
RF Venue, Inc.
8 patents
- Rfaxis
Rfaxis, Inc.
8 patents
- Rheinmetall AIR D…
Rheinmetall AIR Defence AG
8 patents
- Retinal Solutions ◀
Retinal Solutions LLC
8 patents
What this shows Retinal holds 8 patents at rank #33,010, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Retinal
By rank, the assignees closest to #33,010 in granted patent volume.
- Remo, Inc. #33,006 · 8 patents
- Renescience A/S #33,007 · 8 patents
- Resilux N.V. #33,008 · 8 patents
- Respire Medical Holdings LLC #33,009 · 8 patents
- REV Robotics LLC #33,011 · 8 patents
- RF Venue, Inc. #33,012 · 8 patents
- Rfaxis, Inc. #33,013 · 8 patents
- Rheinmetall AIR Defence AG #33,014 · 8 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Retinal's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Retinal's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
21 8th percentile higher than 8% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 12.5% |
| 2019 | 2 | 25.0% |
| 2020 | 3 | 37.5% |
| 2021 | 2 | 25.0% |
Which technologies does Retinal Solutions LLC patent most?
Top 4 of 4 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Retinal Solutions LLC's patent record in context - here's where to go next.
- Retinal Solutions LLC's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #33,062 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Retinal Solutions LLC against Remo, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 20.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.